[Long-term therapy of chronic obstructive respiratory tract syndromes].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003422:Critical Care; D005100:Expectorants / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008134:Long-Term Care; D008173:Lung Diseases, Obstructive / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D011175:Positive-Pressure Respiration; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D011943:Receptors, Adrenergic, beta / Q000627:therapeutic use; D012129:Respiratory Function Tests; D013577:Syndrome; D014970:Xanthines / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005100:Expectorants; D005938:Glucocorticoids; D011943:Receptors, Adrenergic, beta; D014970:Xanthines
Die Langzeittherapie der chronisch-obstruktiven Atemwegssyndrome.